Technical analysis of Silo Pharma, Inc. (SILO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems.
Price Performance
| 1 month | -42.67% |
| 3 months | -71.24% |
| Year-to-date | -65.49% |
| 1 year | -83.29% |
| 3 years | -93.79% |
| 5 years | -98.66% |
52-Week Range
| 52-week High | $15.15 |
| 52-week Low | $1.63 |
| Avg Volume (90d) | 145K |
Technical Indicators
| SMA 50 | $3.65 |
| SMA 200 | $5.30 |
| 30-day Volatility (annualised) | 80.8% |
| Price vs SMA 50 | -51.7% |
| Price vs SMA 200 | -66.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $8.12 | |
| 2025-11 | $6.98 | -14.0% |
| 2025-12 | $5.10 | -26.9% |
| 2026-01 | $5.18 | +1.6% |
| 2026-02 | $5.50 | +6.2% |
| 2026-03 | $5.40 | -1.8% |
| 2026-04 | $6.63 | +22.8% |
| 2026-05 | $6.42 | -3.2% |
| 2026-06 | $6.21 | -3.3% |
| 2026-07 | $4.19 | -32.5% |
| 2026-08 | $2.48 | -40.8% |
| 2026-09 | $1.76 | -29.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.76 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.39 |
| EV / EBITDA | 0.12 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 5.36 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -3.06 |